EDIT
Editas Medicine, Inc.$1.90-0.28 (-12.67%)Prev Close$2.17·MCap$334.9M·P/E—·Vol1.61M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
13
$163.4K
◆
Net Activity
Net Seller
$163.4K
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Editas Medicine, Inc. (EDIT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 13 insider sales totaling $163.4K. The most recent insider transaction was by Burkly Linda (officer: EVP, CHIEF SCIENTIFIC OFFICER), who sold $18.9K worth of shares on Nov 13, 2026. Editas Medicine, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $334.9M.
EDIT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 7,814 | $2.42 | $18.9K | 70,379 |
| Nov 13, 2026 | O'Neill Gilmore Neil | director, officer: CEO | Sell | 21,164 | $2.42 | $51.1K | 265,592 |
| Sep 4, 2026 | Parison Amy | officer: SVP, Chief Financial Officer | Sell | 453 | $3.04 | $1.4K | 13,839 |
| Sep 4, 2026 | O'Neill Gilmore Neil | director, officer: CEO | Sell | 5,124 | $3.04 | $15.6K | 243,189 |
| Sep 4, 2026 | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 709 | $3.04 | $2.2K | 61,660 |
| Aug 5, 2026 | Parison Amy | officer: SVP, Chief Financial Officer | Sell | 678 | $2.58 | $1.7K | 14,292 |
| Jul 29, 2026 | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 4,928 | $2.67 | $13.2K | 62,369 |
| Jun 5, 2026 | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 731 | $2.70 | $2.0K | 67,297 |
| Jun 5, 2026 | O'Neill Gilmore Neil | director, officer: CEO | Sell | 15,380 | $2.70 | $41.5K | 248,313 |
| Jun 5, 2026 | Parison Amy | officer: SVP, Chief Financial Officer | Sell | 464 | $2.70 | $1.3K | 14,970 |
| Dec 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 713 | $2.15 | $1.5K | 0 |
| Dec 3, 2025 | O'Neill Gilmore Neil | CEO | Sell | 5,603 | $2.15 | $12.1K | 0 |
| Dec 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | 461 | $2.15 | $992.58 | 0 |
| Sep 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 710 | $2.60 | $1.8K | 0 |
| Sep 3, 2025 | O'Neill Gilmore Neil | CEO | Sell | 5,592 | $2.60 | $14.5K | 0 |
| Sep 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | 458 | $2.60 | $1.2K | 0 |
| Aug 7, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | 679 | $2.58 | $1.8K | 0 |
| Jul 31, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,121 | $2.49 | $12.8K | 0 |
| Jun 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 726 | $1.72 | $1.3K | 0 |
| Jun 3, 2025 | O'Neill Gilmore Neil | CEO | Sell | 15,192 | $1.72 | $26.2K | 0 |
| Jun 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | 446 | $1.72 | $768.90 | 0 |
| Mar 4, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 2,891 | $1.71 | $4.9K | 0 |
| Mar 4, 2025 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,109 | $1.71 | $7.0K | 0 |
| Mar 4, 2025 | O'Neill Gilmore Neil | CEO | Sell | 16,632 | $1.71 | $28.5K | 0 |
| Dec 3, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 541 | $2.08 | $1.1K | 0 |
| Dec 3, 2024 | O'Neill Gilmore Neil | CEO | Sell | 1,618 | $2.08 | $3.4K | 0 |
| Sep 4, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 518 | $3.42 | $1.8K | 0 |
| Sep 4, 2024 | O'Neill Gilmore Neil | CEO | Sell | 1,555 | $3.42 | $5.3K | 0 |
| Jul 25, 2024 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 11,886 | $5.42 | $64.4K | 0 |
| Jul 19, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 6,619 | $5.21 | $34.5K | 0 |
| Jun 4, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 511 | $5.50 | $2.8K | 0 |
| Jun 4, 2024 | O'Neill Gilmore Neil | CEO | Sell | 12,191 | $5.50 | $67.0K | 0 |
| May 20, 2024 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 22,337 | $5.61 | $125.4K | 0 |
| May 13, 2024 | Hopfield Jessica | Director | Buy | 45,000 | $5.64 | $253.9K | 0 |
| Mar 2, 2024 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Sell | 20,327 | $9.42 | $191.4K | 0 |
| Mar 2, 2024 | O'Neill Gilmore Neil | CEO | Sell | 77,824 | $9.42 | $732.9K | 0 |
| Dec 5, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 103 | $10.90 | $1.1K | 0 |
| Nov 14, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 695 | $8.21 | $5.7K | 0 |
| Nov 7, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 139 | $8.40 | $1.2K | 0 |
| Sep 6, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 103 | $8.82 | $908.46 | 0 |
| Aug 11, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 702 | $8.59 | $6.0K | 0 |
| Aug 8, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 141 | $8.39 | $1.2K | 0 |
| Jul 19, 2023 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Sell | 4,317 | $8.80 | $38.0K | 0 |
| Jun 5, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 105 | $9.50 | $997.82 | 0 |
| Jun 5, 2023 | O'Neill Gilmore Neil | CEO | Sell | 6,486 | $9.50 | $61.6K | 0 |
| May 11, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 668 | $9.87 | $6.6K | 0 |
| May 11, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 949 | $9.87 | $9.4K | 0 |
| May 9, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 135 | $9.51 | $1.3K | 0 |
| Mar 2, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 101 | $8.89 | $897.89 | 0 |
| Mar 2, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 184 | $8.89 | $1.6K | 0 |
Showing 1–50 of 78
1 / 2
EDIT Insider Buying Activity
The following table shows recent insider purchases of Editas Medicine, Inc. (EDIT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 13, 2024 | Hopfield Jessica | Director | Buy | 45,000 | $5.64 | $253.9K | 0 |
EDIT Insider Selling Activity
The following table shows recent insider sales of Editas Medicine, Inc. (EDIT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 7,814 | $2.42 | $18.9K | 70,379 |
| Nov 13, 2026 | O'Neill Gilmore Neil | director, officer: CEO | Sell | 21,164 | $2.42 | $51.1K | 265,592 |
| Sep 4, 2026 | Parison Amy | officer: SVP, Chief Financial Officer | Sell | 453 | $3.04 | $1.4K | 13,839 |
| Sep 4, 2026 | O'Neill Gilmore Neil | director, officer: CEO | Sell | 5,124 | $3.04 | $15.6K | 243,189 |
| Sep 4, 2026 | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 709 | $3.04 | $2.2K | 61,660 |
| Aug 5, 2026 | Parison Amy | officer: SVP, Chief Financial Officer | Sell | 678 | $2.58 | $1.7K | 14,292 |
| Jul 29, 2026 | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 4,928 | $2.67 | $13.2K | 62,369 |
| Jun 5, 2026 | Burkly Linda | officer: EVP, CHIEF SCIENTIFIC OFFICER | Sell | 731 | $2.70 | $2.0K | 67,297 |
| Jun 5, 2026 | O'Neill Gilmore Neil | director, officer: CEO | Sell | 15,380 | $2.70 | $41.5K | 248,313 |
| Jun 5, 2026 | Parison Amy | officer: SVP, Chief Financial Officer | Sell | 464 | $2.70 | $1.3K | 14,970 |
| Dec 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 713 | $2.15 | $1.5K | 0 |
| Dec 3, 2025 | O'Neill Gilmore Neil | CEO | Sell | 5,603 | $2.15 | $12.1K | 0 |
| Dec 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | 461 | $2.15 | $992.58 | 0 |
| Sep 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 710 | $2.60 | $1.8K | 0 |
| Sep 3, 2025 | O'Neill Gilmore Neil | CEO | Sell | 5,592 | $2.60 | $14.5K | 0 |
| Sep 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | 458 | $2.60 | $1.2K | 0 |
| Aug 7, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | 679 | $2.58 | $1.8K | 0 |
| Jul 31, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,121 | $2.49 | $12.8K | 0 |
| Jun 3, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 726 | $1.72 | $1.3K | 0 |
| Jun 3, 2025 | O'Neill Gilmore Neil | CEO | Sell | 15,192 | $1.72 | $26.2K | 0 |
| Jun 3, 2025 | Parison Amy | SVP, Chief Financial Officer | Sell | 446 | $1.72 | $768.90 | 0 |
| Mar 4, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 2,891 | $1.71 | $4.9K | 0 |
| Mar 4, 2025 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,109 | $1.71 | $7.0K | 0 |
| Mar 4, 2025 | O'Neill Gilmore Neil | CEO | Sell | 16,632 | $1.71 | $28.5K | 0 |
| Dec 3, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 541 | $2.08 | $1.1K | 0 |
| Dec 3, 2024 | O'Neill Gilmore Neil | CEO | Sell | 1,618 | $2.08 | $3.4K | 0 |
| Sep 4, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 518 | $3.42 | $1.8K | 0 |
| Sep 4, 2024 | O'Neill Gilmore Neil | CEO | Sell | 1,555 | $3.42 | $5.3K | 0 |
| Jul 25, 2024 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 11,886 | $5.42 | $64.4K | 0 |
| Jul 19, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 6,619 | $5.21 | $34.5K | 0 |
| Jun 4, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | 511 | $5.50 | $2.8K | 0 |
| Jun 4, 2024 | O'Neill Gilmore Neil | CEO | Sell | 12,191 | $5.50 | $67.0K | 0 |
| May 20, 2024 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | 22,337 | $5.61 | $125.4K | 0 |
| Mar 2, 2024 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Sell | 20,327 | $9.42 | $191.4K | 0 |
| Mar 2, 2024 | O'Neill Gilmore Neil | CEO | Sell | 77,824 | $9.42 | $732.9K | 0 |
| Dec 5, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 103 | $10.90 | $1.1K | 0 |
| Nov 14, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 695 | $8.21 | $5.7K | 0 |
| Nov 7, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 139 | $8.40 | $1.2K | 0 |
| Sep 6, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 103 | $8.82 | $908.46 | 0 |
| Aug 11, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 702 | $8.59 | $6.0K | 0 |
| Aug 8, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 141 | $8.39 | $1.2K | 0 |
| Jul 19, 2023 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Sell | 4,317 | $8.80 | $38.0K | 0 |
| Jun 5, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 105 | $9.50 | $997.82 | 0 |
| Jun 5, 2023 | O'Neill Gilmore Neil | CEO | Sell | 6,486 | $9.50 | $61.6K | 0 |
| May 11, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 668 | $9.87 | $6.6K | 0 |
| May 11, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 949 | $9.87 | $9.4K | 0 |
| May 9, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 135 | $9.51 | $1.3K | 0 |
| Mar 2, 2023 | Eaton Bruce | EVP, CBO AND CTO | Sell | 101 | $8.89 | $897.89 | 0 |
| Mar 2, 2023 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | 184 | $8.89 | $1.6K | 0 |
EDIT Insiders
Similar Stocks to EDIT
VRTX
Vertex Pharmaceuticals Incorporated
$536.14-0.42%
$138.69B
REGN
Regeneron Pharmaceuticals, Inc.
$948.88-0.62%
$99.23B
MRNA
Moderna, Inc.
$214.97-3.55%
$93.61B
RVMD
Revolution Medicines, Inc.
$166.45-3.42%
$39.08B
INSM
Insmed Incorporated
$122.96+1.38%
$26.58B
UTHR
United Therapeutics Corporation
$585.50-0.96%
$25.18B
INCY
Incyte Corporation
$120.12-0.66%
$24.66B
ALNY
Alnylam Pharmaceuticals, Inc.
$159.51-3.31%
$21.41B